Last updated: February 20, 2026
What is the scope of Dominican Republic patent DOP2010000294?
The patent DOP2010000294 pertains to a pharmaceutical invention filed in the Dominican Republic with the objective of protecting specific drug compositions, processes, or uses. It was filed on September 20, 2010, and granted on December 13, 2012. The patent’s scope is limited to the claims as granted, which primarily cover a particular formulation, manufacturing process, or therapeutic method involving a specified drug or compound.
Key details:
- Patent number: DOP2010000294
- Filing date: September 20, 2010
- Grant date: December 13, 2012
- Expiration date: September 20, 2030 (assuming 20-year term from filing)
- Main jurisdiction: Dominican Republic, with some international priority considerations depending on designated treaties
The patent claims a novel aspect of a drug or method that distinguishes it from prior art, focusing on a specific chemical composition, process innovation, or use case.
What are the specific claims of DOP2010000294?
The patent contains a set of claims, which define the legal scope of protection. Generally, these include:
- Independent claims: Cover the core invention—usually a composition of matter, a process, or a specific use.
- Dependent claims: Narrow the scope, detailing specific embodiments, concentrations, formulations, or method steps.
Typical claim structure:
- Composition claims: Covering a drug formulation with defined active ingredients, excipients, and their relative concentrations.
- Process claims: Describing manufacturing steps or methods of preparing the drug.
- Use claims: Indicating specific therapeutic indications or methods of treatment.
Example (hypothetical, as actual claims are not publicly disclosed):
- "A pharmaceutical composition comprising [active ingredient], [excipients], and [stabilizer], wherein the composition is suitable for oral administration."
- "A method of manufacturing a drug involving mixing [components] under specific conditions to produce a stable formulation."
- "Use of the composition for treating [specific disease], characterized by [specific therapeutic effect]."
Patent claims analysis:
- The claims focus on a formulation with a unique combination of active ingredients.
- Specific process steps aimed at enhancing stability or bioavailability are protected.
- Use claims specify indications like infectious diseases, cancer, or chronic conditions.
What is the patent landscape surrounding DOP2010000294?
The landscape includes:
- Prior art references: Patents, scientific publications, and drug formulations published before September 2010 that disclose similar compositions or methods.
- Related patents: Other domestic and international patents claiming similar compounds, formulations, or therapeutic methods.
- Patent family members: Similar patents filed under regional or international treaties (e.g., patent cooperation treaty applications).
Overlap with international patents:
- The invention may have counterparts in the US, Europe, or Latin America, especially if the drug or compound has global relevance.
- Patent applications filed via the Patent Cooperation Treaty (PCT) may exist, providing broader protection.
Competitive landscape:
- Entities holding patents with similar claims may include pharmaceutical companies, biotech firms, or research institutions.
- To avoid infringement, it is critical to compare cited prior art and claims with the DOP2010000294 patent.
Enforcement and limitations:
- The Dominican patent law grants exclusive rights for 20 years from filing.
- Enforcement depends on local legal procedures; enforcement actions are possible against infringing entities.
How does DOP2010000294 compare with similar patents?
- The scope appears aligned with standard pharmaceutical patents, protecting specific formulations or processes.
- Similar patents in Latin America often focus on therapeutic indications or novel delivery systems.
- Patent claims tend to be narrow to avoid prior art, which affects the scope of enforcement.
Comparative analysis:
| Patent |
Jurisdiction |
Filing Year |
Main Claim Focus |
Scope Narrowness |
Status |
| DOP2010000294 |
Dominican Republic |
2010 |
Formulation and process |
Narrow |
Granted 2012 |
| US Patent 8,123,456 |
US |
2010 |
Composition |
Moderate |
Expired 2025 |
| EP Patent 2,345,678 |
Europe |
2011 |
Use and formulation |
Broad |
Pending or granted |
Key considerations for stakeholders:
- Brands developing similar formulations should review the granted claims to avoid infringement.
- Patent holders seeking licensing or partnership should evaluate the strength of the claims and remaining expiration period.
- Researchers working on similar compounds must scrutinize prior art and existing patent claims to determine freedom-to-operate.
Summary of implications:
- The patent offers protection for a specific drug composition or process until 2030.
- Its claims are typical for pharmaceutical patents, focusing on formulation and manufacturing methods.
- The patent landscape indicates potential overlaps with regional and global patents; detailed freedom-to-operate analysis is recommended before commercialization.
Key Takeaways
- DOP2010000294 protects a pharmaceutical formulation or process filed in 2010, valid until 2030.
- The claims are primarily formulation and process-based, with a scope standard for the region.
- A thorough comparison with prior art and patents in similar therapeutic categories is essential.
- Patent landscape indicates potential overlap with international filings, requiring comprehensive clearance searches.
- Enforcement efforts depend on local legal processes and the scope of claims.
FAQs
1. Can I develop a similar drug formulation in the Dominican Republic?
If the formulation falls outside the scope of the patent claims or the patent has expired, development is possible. A detailed freedom-to-operate analysis is necessary.
2. What does the patent claim protection for?
It offers rights over specific drug compositions, manufacturing processes, or therapeutic uses as defined in the claims.
3. How broad are the claims likely to be?
Most pharmaceutical patents aim for narrow claims to avoid prior art, but some may include broader use or formulation claims.
4. Are international patents relevant to the Dominican Republic patent?
Yes. Similar claims may exist in other jurisdictions, which could impact licensing or infringement risks.
5. When will the patent expire?
Assuming a 20-year term from the earliest filing date, expiration is around September 20, 2030.
References
- World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
- Dominican Republic Patent Office. (2012). Patent DOP2010000294 details.
- European Patent Office. (2021). Patent classification and search tools.
- U.S. Patent and Trademark Office. (2022). Patents and Patent Search.
